These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 8201382)

  • 1. Antibody targeting in metastatic colon cancer: a phase I study of monoclonal antibody F19 against a cell-surface protein of reactive tumor stromal fibroblasts.
    Welt S; Divgi CR; Scott AM; Garin-Chesa P; Finn RD; Graham M; Carswell EA; Cohen A; Larson SM; Old LJ
    J Clin Oncol; 1994 Jun; 12(6):1193-203. PubMed ID: 8201382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biokinetics of a F(ab')3 iodine-131 labeled antigen binding construct (Mab 35) directed against CEA in patients with colorectal carcinoma.
    Storto G; Buchegger F; Waibel R; Kuenzi G; Offord RE; Schubiger PA; Gillet M; Delaloye AB
    Cancer Biother Radiopharm; 2001 Oct; 16(5):371-9. PubMed ID: 11776754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative analysis of antibody localization in human metastatic colon cancer: a phase I study of monoclonal antibody A33.
    Welt S; Divgi CR; Real FX; Yeh SD; Garin-Chesa P; Finstad CL; Sakamoto J; Cohen A; Sigurdson ER; Kemeny N
    J Clin Oncol; 1990 Nov; 8(11):1894-906. PubMed ID: 2230877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population pharmacokinetics of antifibroblast activation protein monoclonal antibody F19 in cancer patients.
    Tanswell P; Garin-Chesa P; Rettig WJ; Welt S; Divgi CR; Casper ES; Finn RD; Larson SM; Old LJ; Scott AM
    Br J Clin Pharmacol; 2001 Feb; 51(2):177-80. PubMed ID: 11259992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose escalation trial of indium-111-labeled anti-carcinoembryonic antigen chimeric monoclonal antibody (chimeric T84.66) in presurgical colorectal cancer patients.
    Wong JY; Chu DZ; Yamauchi D; Odom-Maryon TL; Williams LE; Liu A; Esteban JM; Wu AM; Primus FJ; Beatty JD; Shively JE; Raubitschek AA
    J Nucl Med; 1998 Dec; 39(12):2097-104. PubMed ID: 9867150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblast activation protein: purification, epitope mapping and induction by growth factors.
    Rettig WJ; Su SL; Fortunato SR; Scanlan MJ; Raj BK; Garin-Chesa P; Healey JH; Old LJ
    Int J Cancer; 1994 Aug; 58(3):385-92. PubMed ID: 7519584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody localization in human renal cell carcinoma: a phase I study of monoclonal antibody G250.
    Oosterwijk E; Bander NH; Divgi CR; Welt S; Wakka JC; Finn RD; Carswell EA; Larson SM; Warnaar SO; Fleuren GJ
    J Clin Oncol; 1993 Apr; 11(4):738-50. PubMed ID: 8478666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human antibody derivatives against the fibroblast activation protein for tumor stroma targeting of carcinomas.
    Mersmann M; Schmidt A; Rippmann JF; Wüest T; Brocks B; Rettig WJ; Garin-Chesa P; Pfizenmaier K; Moosmayer D
    Int J Cancer; 2001 Apr; 92(2):240-8. PubMed ID: 11291052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complementation of intracavitary and intravenous administration of a monoclonal antibody (B72.3) in patients with carcinoma.
    Colcher D; Esteban J; Carrasquillo JA; Sugarbaker P; Reynolds JC; Bryant G; Larson SM; Schlom J
    Cancer Res; 1987 Aug; 47(15):4218-24. PubMed ID: 3607761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraoperative detection of occult colon cancer micrometastases using 125 I-radiolabled monoclonal antibody CC49.
    Cote RJ; Houchens DP; Hitchcock CL; Saad AD; Nines RG; Greenson JK; Schneebaum S; Arnold MW; Martin EW
    Cancer; 1996 Feb; 77(4):613-20. PubMed ID: 8616751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibroblast activation protein: differential expression and serine protease activity in reactive stromal fibroblasts of melanocytic skin tumors.
    Huber MA; Kraut N; Park JE; Schubert RD; Rettig WJ; Peter RU; Garin-Chesa P
    J Invest Dermatol; 2003 Feb; 120(2):182-8. PubMed ID: 12542520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical implications of fibroblast activation protein in patients with colon cancer.
    Henry LR; Lee HO; Lee JS; Klein-Szanto A; Watts P; Ross EA; Chen WT; Cheng JD
    Clin Cancer Res; 2007 Mar; 13(6):1736-41. PubMed ID: 17363526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer.
    Scott AM; Wiseman G; Welt S; Adjei A; Lee FT; Hopkins W; Divgi CR; Hanson LH; Mitchell P; Gansen DN; Larson SM; Ingle JN; Hoffman EW; Tanswell P; Ritter G; Cohen LS; Bette P; Arvay L; Amelsberg A; Vlock D; Rettig WJ; Old LJ
    Clin Cancer Res; 2003 May; 9(5):1639-47. PubMed ID: 12738716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intratumoral distribution of radiolabeled antibody and radioimmunotherapy in experimental liver metastases model of nude mouse.
    Sato N; Saga T; Sakahara H; Yao Z; Nakamoto Y; Zhang M; Kuroki M; Matsuoka Y; Iida Y; Konishi J
    J Nucl Med; 1999 Apr; 40(4):685-92. PubMed ID: 10210230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers.
    Garin-Chesa P; Old LJ; Rettig WJ
    Proc Natl Acad Sci U S A; 1990 Sep; 87(18):7235-9. PubMed ID: 2402505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and tumor targeting of 131I-labeled F(ab')2 fragments of the chimeric monoclonal antibody G250: preclinical and clinical pilot studies.
    Brouwers A; Mulders P; Oosterwijk E; Buijs W; Corstens F; Boerman O; Oyen W
    Cancer Biother Radiopharm; 2004 Aug; 19(4):466-77. PubMed ID: 15453961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preselection of patients with high TAG-72 antigen expression leads to targeting of 94% of known metastatic tumor sites with monoclonal antibody I-131-CC49.
    Kostakoglu L; Divgi CR; Hilton S; Cordon-Cardo C; Scott AM; Kalaigian H; Finn RD; Schlom J; Larson SM
    Cancer Invest; 1994; 12(6):551-8. PubMed ID: 7994589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioimmunoguided surgery.
    Veroux G; Nicosia AS; Veroux P; Cardillo P; Veroux M; Amodeo C
    Hepatogastroenterology; 1999; 46(30):3099-108. PubMed ID: 10626169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pilot radioimmunotherapy trial with 131I-labeled murine monoclonal antibody CC49 and deoxyspergualin in metastatic colon carcinoma.
    Divgi CR; Scott AM; Gulec S; Broussard EK; Levy N; Young C; Capitelli P; Daghighian F; Williams JM; Finn RD
    Clin Cancer Res; 1995 Dec; 1(12):1503-10. PubMed ID: 9815950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation and heteromeric structure of the fibroblast activation protein in normal and transformed cells of mesenchymal and neuroectodermal origin.
    Rettig WJ; Garin-Chesa P; Healey JH; Su SL; Ozer HL; Schwab M; Albino AP; Old LJ
    Cancer Res; 1993 Jul; 53(14):3327-35. PubMed ID: 8391923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.